Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Fenfluramine

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05232630Phase 4Completed

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

Showing all 1 trials

Research Network

Common Treatments

  • Fenfluramine1

Active Sponsors

  • Hospital Ruber Internacional1
  • Zogenix, Inc.1

Top Investigators

Related Conditions

  • Syngap1 Encephalopathy1
  • Continuous Spike And Waves During Slow Sleep1
  • Inv Dup15 Encephalopathy1
  • Stxbp1 Encephalopathy With Epilepsy1
  • Refractory Epilepsy1

Activity Timeline